Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 12/7/06 AVI BioPharma Announces Clinical Development Initiative for Muscular Dystrophy 12/4/06 AVI BioPharma Awarded $28 Million Biodefense Research Contract by Department of Defense/DTRA 11/27/06 AVI Biopharma 2006 Third Quarter Financial Results Conference Call Transcript 11/10/06 AVI BioPharma Announces Positive Clinical Trial Results Delivering NEUGENE Antisense Drugs to the Central Nervous System 11/8/06 AVI BioPharma Reports Third Quarter Financial Results 11/6/06 AVI BioPharma to Present Strategic Overview at Two Investor Conferences 11/1/06 AVI BioPharma Announces 2006 Third Quarter Financial Results Conference Call 10/31/06 AVI BioPharma Discusses Phase II Cardiovascular Clinical Study 10/27/06 AVI BioPharma Publishes Preclinical Data Showing NEUGENE Antisense Inhibition of Multiple Strains of Influenza A Virus 10/19/06 AVI BioPharma Presents Successful Trial Results Using NEUGENE Antisense to Alter Drug Metabolism in Humans Pagination First page « first Previous page ‹ previous … Page 74 Page 75 Page 76 Page 77 Current page 78 Page 79 Page 80 Page 81 Page 82 Next page next › Last page last » Displaying 771 - 780 of 813 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Date Title 12/7/06 AVI BioPharma Announces Clinical Development Initiative for Muscular Dystrophy 12/4/06 AVI BioPharma Awarded $28 Million Biodefense Research Contract by Department of Defense/DTRA 11/27/06 AVI Biopharma 2006 Third Quarter Financial Results Conference Call Transcript 11/10/06 AVI BioPharma Announces Positive Clinical Trial Results Delivering NEUGENE Antisense Drugs to the Central Nervous System 11/8/06 AVI BioPharma Reports Third Quarter Financial Results 11/6/06 AVI BioPharma to Present Strategic Overview at Two Investor Conferences 11/1/06 AVI BioPharma Announces 2006 Third Quarter Financial Results Conference Call 10/31/06 AVI BioPharma Discusses Phase II Cardiovascular Clinical Study 10/27/06 AVI BioPharma Publishes Preclinical Data Showing NEUGENE Antisense Inhibition of Multiple Strains of Influenza A Virus 10/19/06 AVI BioPharma Presents Successful Trial Results Using NEUGENE Antisense to Alter Drug Metabolism in Humans Pagination First page « first Previous page ‹ previous … Page 74 Page 75 Page 76 Page 77 Current page 78 Page 79 Page 80 Page 81 Page 82 Next page next › Last page last » Displaying 771 - 780 of 813